BJL
KURA icon

Brighton Jones LLC’s Kura Oncology KURA Stock Holding History

Brighton Jones LLC’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
22,947
+9,292
+68% +$87.7K ﹤0.01% 1142
2026
Q1 		$111K Buy
+13,655
New +$117K ﹤0.01% 1121
2025
Q4 		– Sell
-12,196
Closed -$108K – 545
2025
Q3 		$108K Buy
+12,196
New +$86.9K ﹤0.01% 989

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Brighton Jones LLC's KURA Position: Q2 2026 in Review

Brighton Jones LLC increased its Kura Oncology (KURA) stake by 68% in Q2 2026, buying an estimated $87.7K and bringing the position to 22,947 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Brighton Jones LLC first reported a position in KURA in Q3 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Brighton Jones LLC held 22,947 shares of Kura Oncology worth $252K as of Q2 2026.
  • Brighton Jones LLC bought 9,292 Kura Oncology shares in Q2 2026, an estimated $87.7K.
  • Kura Oncology made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1142 holding.
  • Brighton Jones LLC first reported a position in Kura Oncology in Q3 2025 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.